228 related articles for article (PubMed ID: 38594359)
1. Biomarker profiling to determine clinical impact of microRNAs in cognitive disorders.
Zhai W; Zhao M; Wei C; Zhang G; Qi Y; Zhao A; Sun L
Sci Rep; 2024 Apr; 14(1):8270. PubMed ID: 38594359
[TBL] [Abstract][Full Text] [Related]
2. China Alzheimer's Disease and Neurodegenerative Disorder Research (CANDOR) -A Prospective Cohort Study for Alzheimer's Disease and Vascular Cognitive Impairment.
Li S; Dong H; Wang Y; Wang S; Lv X; Dong M; Tian S; Shi J
J Prev Alzheimers Dis; 2024; 11(1):214-221. PubMed ID: 38230734
[TBL] [Abstract][Full Text] [Related]
3. Vascular and Neurodegenerative Markers for the Prediction of Post-Stroke Cognitive Impairment: Results from the TABASCO Study.
Molad J; Hallevi H; Korczyn AD; Kliper E; Auriel E; Bornstein NM; Ben Assayag E
J Alzheimers Dis; 2019; 70(3):889-898. PubMed ID: 31282420
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
5. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
[TBL] [Abstract][Full Text] [Related]
6. Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis.
Shi D; Han M; Liu W; Tao J; Chen L
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520951686. PubMed ID: 33094634
[TBL] [Abstract][Full Text] [Related]
7. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Nagaraj S; Laskowska-Kaszub K; Dębski KJ; Wojsiat J; Dąbrowski M; Gabryelewicz T; Kuźnicki J; Wojda U
Oncotarget; 2017 Mar; 8(10):16122-16143. PubMed ID: 28179587
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs and mild cognitive impairment: A systematic review.
Piscopo P; Lacorte E; Feligioni M; Mayer F; Crestini A; Piccolo L; Bacigalupo I; Filareti M; Ficulle E; Confaloni A; Vanacore N; Corbo M
Ageing Res Rev; 2019 Mar; 50():131-141. PubMed ID: 30472218
[TBL] [Abstract][Full Text] [Related]
9. Exosomal MicroRNA-Based Predictive Model for Preclinical Alzheimer's Disease: A Multicenter Study.
Jia L; Zhu M; Yang J; Pang Y; Wang Q; Li T; Li F; Wang Q; Li Y; Wei Y
Biol Psychiatry; 2022 Jul; 92(1):44-53. PubMed ID: 35221095
[TBL] [Abstract][Full Text] [Related]
10. Differentially Expressed miR-511-3p in Stroke Patients Predicts the Presence of Post-Stroke Cognitive Impairment.
Wang T; Zhao W; Liu Y; Song K; Zeng J; Wang Z
Dement Geriatr Cogn Disord; 2024; 53(1):12-18. PubMed ID: 38056437
[TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
Chum PP; Hakim MA; Behringer EJ
J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451
[TBL] [Abstract][Full Text] [Related]
12. miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.
Han SW; Pyun JM; Bice PJ; Bennett DA; Saykin AJ; Kim SY; Park YH; Nho K
Alzheimers Res Ther; 2024 Jan; 16(1):5. PubMed ID: 38195609
[TBL] [Abstract][Full Text] [Related]
13. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of MicroRNAs in Alzheimer's disease: a systematic review and meta-analysis.
Yoon S; Kim SE; Ko Y; Jeong GH; Lee KH; Lee J; Solmi M; Jacob L; Smith L; Stickley A; Carvalho AF; Dragioti E; Kronbichler A; Koyanagi A; Hong SH; Thompson T; Oh H; Salazar de Pablo G; Radua J; Shin JI; Fusar-Poli P
Mol Psychiatry; 2022 May; 27(5):2405-2413. PubMed ID: 35264731
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
16. Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment.
Sandau US; Wiedrick JT; Smith SJ; McFarland TJ; Lusardi TA; Lind B; Harrington CA; Lapidus JA; Galasko DR; Quinn JF; Saugstad JA
J Alzheimers Dis; 2020; 78(1):245-263. PubMed ID: 32955460
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of miR-21, miR-124, miR-132, and miR-200b serums in post-stroke cognitive impairment patients.
Yuan M; Guo YS; Zhang XX; Gao ZK; Shen XY; Han Y; Bi X
Folia Neuropathol; 2022; 60(2):228-236. PubMed ID: 35950475
[TBL] [Abstract][Full Text] [Related]
18. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
He H; Liu A; Zhang W; Yang H; Zhang M; Xu H; Liu Y; Hong B; Yan F; Yue L; Wang J; Xiao S; Xie Z; Wang T
J Alzheimers Dis; 2021; 83(2):779-790. PubMed ID: 34366343
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of candidate mRNAs and miRNAs as biomarkers for mild cognitive impairment and Alzheimer's disease.
Qin H; Hu C; Zhao X; Tian M; Zhu B
Int J Neurosci; 2023 Jan; 133(1):89-102. PubMed ID: 33541173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
